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INTRODUCTION
Intra-and inter-fractional variations degrade the precision of tumor irradiation. These uncertainties are taken into account in treatment planning as margins around the clinical target volume (CTV). In the International Commission on Radiation Units and Measurements (ICRU) Report 62 (Supplement to ICRU Report 50), two types of margin are defined: the internal margin (IM), which comes from variations in the size, shape, and relative position of the CTV to anatomical reference points; and the set-up margin (SM), which comes from uncertainties in patient positioning and alignment. 1, 2) These margins should be minimized to avoid radiation damage to normal tissues while ensuring an adequate irradiating dose to the target.
In the thoracic region, lung tumor motion during respiration can significantly deteriorate dose concentration due to the high-density contrast between tumor and the surrounding normal tissues. This is particularly the case in carbon ion beam therapy, which is subject to the characteristic property of Bragg peak.
In our hospital, patients undergo carbon ion beam treatment with a custom-made immobilization device to improve patient positional reproducibility throughout the treatment course. As two orthogonal fixed beam ports (vertical and horizontal directions) are used, the patient bed is tilted around the superior-inferior (SI) direction to expand beamangle selection (details are described in Materials and Method). The immobilization must therefore be more constrictive compared to that with other commercially available devices to reduce movement, and is hence expected to reduce lung tumor motion during respiration by suppressing expansion of the chest wall.
A number of reports have investigated intrafractional respiratory motion using different modalities such as fluoroscopy, electronic portal images, MRI, or conventional three-dimensional CT, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] with some also assessing the effect of patient immobilization. [16] [17] [18] [19] [20] [21] To our knowledge, however, no reports have quantified lung tumor motion using the immobilization device employed by fourdimensional computed tomography (4DCT). [22] [23] [24] [25] The 4DCT method is more suitable than other modalities for estimating the range of lung tumor movement as it provides time resolved information about the tumor with less blur and artifacts.
Here, we assessed the effect of patient immobilization on intrafractional respiratory motion in lung tumor patients using 4DCT.
MATERIALS AND METHODS

Patients and data acquisition
Subjects for this study comprised 17 inpatients (mean age: 71 years ; SD: ± 10 years) in our hospital receiving carbon ion beam lung treatment. Each patient consented to participate in the study, which was approved by the Institutional Review Board for human research of the National Institute of Radiological Sciences (NIRS). Patient characteristics are summarized in Table 1 .
CT scans were performed in 4D mode with a 256-slice CT scanner (Toshiba Medical, Tochigi, Japan). 27, 28) The respiratory signal was derived from a respiratory sensing system consisting of a position-sensitive detector (PSD) and infrared-emitting light marker (Toyonaka Kenkyujo, Osaka, Japan) attached on the patient's chest. 29) Scan conditions were slice collimation of 256 × 0.5 mm, 0.5 sec per rotation, and scan time of less than 6 sec to obtain a single respiratory cycle. Backprojection was done in a voxel size of 0.78 mm × 0.78 mm × 1.0 mm.
In our lung treatment protocol, a prescribed dose is delivered to the target with four beam ports from gantry angles on the ipsilateral side of the tumor, which consist of two pairs at an orthogonal beam angle, with one beam of each pair tilted 40° to achieve a better dose distribution. Since carbon ion beam ports are fixed in anterior-posterior (AP) and left-right (LR) directions, the patient bed is tilted ± 20°a round the superior-inferior (SI) direction. Patients are therefore maintained in a fixed position on the tilted patient bed by an immobilization device (Fig. 1) , which is molded by softening above 45°C and fitting to the patient's body. This device consists of a hydraulic urethane base and thermoplastic shell that covers the upper half of the patient's body, with fixation adjusted by a hook-and-loop fastener. To replicate a single fraction of this lung protocol, the patients underwent 4DCT with their bodies held in position with the immobilization device. The details for the patient positions and rotation angles when undergoing 4DCT are listed in Table 1 .
Data analysis
Two metrics were analyzed using the 4DCT data sets; (i) GTV center of mass (COM) trajectory, and (ii) IM. These were compared between respiratory-ungated and -gated treatment scenarios. 4DCT data sets for a single respiratory cycle were subdivided into 10 phases (T0, peak inhalation; T50, peak exhalation) based on the amplitude acquired from the external respiratory signal. The respiratory ungated and gated phases were defined as 10 phases (T0-T90) and 3 phases correlating to a 30% duty cycle (T40-T60) around Abbreviations: SCC = squamous cell carcinoma, ADC = adenocarcinoma peak exhalation, respectively. A medical physicist manually delineated the GTV for each respiratory phase by referring to the contours at peak exhalation as defined by a certified radiation oncologist. The GTV-COM trajectory was calculated based on the GTV contours at consecutive phases. The range of IM was described by the maximal distance of the GTV bounding box, defined as the minimum cube containing the GTV contours, at the peak exhalation phase from that at other phases, for each of the left/right, anterior/posterior, and superior/inferior directions.
Statistical analysis
To assess the difference of the magnitude of tumor displacement in between the upper and lower lobes, the GTV-COM displacements in LR, AP and SI directions averaged in each lobe were compared based on Welch's t-test for independent two samples after testing the normality of the distribution for each sample by Kolmogorov-Smirnov test. The comparison was done for ungated and gated strategies.
RESULTS
The average GTV-COM displacement from the peak exhalation position across all patients is summarized in Table 2 . The mean (± SD) GTV-COM displacements were 0.6 (± 0.8) / 0.9 (± 1.2) mm, 2.0 (± 1.4) / 0.4 (± 0.7) mm, and 0.2 (± 0.5) / 7.8 (± 6.9) mm in left/right, anterior/posterior, and superior/inferior directions, respectively. These were reduced in the respiratory-gated case to 0.3 (± 0.4) / 0.4 (± 0.6) mm (left/right), 0.8 (± 0.7) / 0.3 (± 0.5) mm (anterior/ posterior), and 0.1 (± 0.2) / 2.8 (± 2.9) mm (superior/inferior). The range of tumor motion for patient number 1 was the largest among all patients and can be explained by the tumor Table 2 . GTV-COM displacements from the peak exhalation position for gated or ungated treatment strategies.
Unit (mm)
No. Abbreviations: SD = standard deviation, Min = minimum, Max = maximum location being in close proximity to the diaphragm. The GTV-COM displacement observed in each lung lobe is summarized in Table 3 . With regard to the respiratoryungated case, a significant GTV-COM displacement was seen in the inferior direction in the lower lobe with a mean (± SD) displacement of 12.0 (± 5.7) mm, while the mean displacements in other directions in each lobe were less than 2 mm, except for in the anterior directions in the lower lobe, Table 3 . GTV-COM displacement for ungated and gated treatment strategies in upper, middle, and lower lobes. Abbreviations: SD = standard deviation with the mean (± SD) IM being 2.7 (± 1.3) mm. With regard to the respiratory-gated case, the mean (± SD) GTV-COM displacement in the inferior direction was reduced to 4.5 (± 2.6) mm, in the lower lobe, and the mean GTV-COM displacements in other directions in each lobe were generally less than 1 mm, with the SD being less than 1 mm. The average IMs observed in each lung lobe for both ungated and gated cases are shown in Table 4 . With regard to the respiratory-ungated case, as is the GTV-COM displacement, a significant IM was seen in the inferior direction in the lower lobe with a mean (± SD) IM of 12.4 (± 5.6) mm. The mean IM in other directions in each lobe were less than 2 mm, except for in the anterior directions in the lower lobe, with the mean (± SD) IM being 3.3 (± 2.2) mm. With regard to the respiratory-gated case, the mean (± SD) IM in the inferior direction in the lower lobe was reduced to 4.9 (± 2.5) mm, and the mean IM in other directions in each lobe were generally less than 1 mm, with the SD being less than 1 mm. The difference of the results between the two metrics, the GTV-COM displacements form the peak exhalation position and the IM around the peak exhalation, was due to the deformation of the GTV.
The magnitude of the GTV-COM displacements during one respiratory cycle along LR, AP and SI directions averaged in the upper and lower lobes are given in Table 5 . For the respiratory-ungated strategy, the mean (± SD) displacements in the upper lobe (6 patients) were 1.3 (± 0.7) mm (LR), 1.8 (± 0.7) mm (AP), and 2.2 (± 1.2) mm (SI); while in the lower lobe (10 patients), 1.7 (± 1.1) mm (LR), 2.9 (± 1.0) mm (AP), and 12.0 (± 5.7) mm (SI). Comparing these results between upper and lower lobes based on Welch's t-test, significant differences were seen in AP (p < 0.02) and SI (p < 0.0002) directions, which reflects the effect of diaphragm motion. On the other hand, for the respiratorygated strategy, the mean (± SD) displacements in the upper lobe were 0.8 (± 0.7) mm (LR), 1.0 (± 0.7) mm (AP), and 0.5 (± 0.3) mm (SI), while in the lower lobe, 0.7 (± 0.3) mm (LR), 1.1 (± 0.6) mm (AP), and 4.5 (± 2.6) mm (SI). A significant difference between in the upper and lower lobes was seen only in SI direction (p < 0.0005).
We should comment that for the upper lobe all the patients were studied in the supine position; while for the lower lobe, 3 patients were studied in the supine position and 7 patients were studied in the prone position, where no significant difference (p = 0.05) was observed between in the upper and lower position.
DISCUSSION
We quantified the GTV-COM trajectory and calculated IM using 4DCT lung data sets and compared them between respiratory-ungated and -gated treatment scenarios. We showed a quantitative reduction in the intrafractional respiratory motion for the respiratory-gated strategy, with the mean (± SD) tumor motion in the inferior direction reduced from 12.0 (± 5.7) mm to 4.5 (± 2.6) mm in the lower lobe, as determined by GTV-COM trajectory, which quantitatively shows the effectiveness of the respiratory-gated treatment to restrict the respiratory tumor motion.
Our previous study reported the lung GTV-COM displacements during a single respiratory cycle, averaged for 14 patients (mean age, 76 years; SD, ± 8) under free-breathing conditions without immobilization using 4DCT, with mean (± SD) ranges of 1.9 (± 1.6) mm, 4.0 (± 2.3) mm, and 10.3 (± 7.1) mm in LR, AP, and SI directions, respectively. 30) Computed from Table 2 , the mean (± SD) ranges of GTV-COM displacements with immobilization are 1.5 (± 1.0) mm, 2.4 (± 1.0) mm, and 7.9 (± 6.7) mm in LR, AP, and SI directions, respectively. Compared to these findings, our present results showed that immobilization decreased mean range of displacement by 0.4 mm, 1.6 mm, and 2.4 mm in the respective directions, indicating the possibility that immobilization reduces the internal tumor motion.
Since the respiratory tumor motion is significantly affected by diaphragm motion, the effect of the immobilization should be analyzed separately in the upper and lower lobes. For the case without immobilization, the mean (± SD) ranges of GTV-COM displacements in the upper lobes (7 patients) were 2.3 (± 1.8) mm, 4.2 (± 2.3) mm, and 6.6 (± 3.9) mm in LR, AP, and SI directions, respectively, while, in the lower lobe (6 patients), 1.4 (± 1.2) mm (LR), 3.9 (± 2.5) mm (AP), and 14.0 (± 8.0) mm (SI). 30) Comparing these results with those in Table 5 based on Welch's t-test, immobilization showed the significant reduction of motion for AP (p < 0.03) and SI (p < 0.02) in the upper lobe. In the lower lobe, no significant reduction was observed, which mainly because tumor motions were significantly affected by the diaphragm motion when the tumor located in close proximity to the diaphragm as seen in patient number 1.
Immobilization is an important issue in stereotactic radiotherapy as well as in carbon ion beam therapy. Several studies have investigated the effectiveness of immobilization in reducing intrafractional tumor or diaphragm movement in Table 5 . Mean (± SD) GTV-COM displacements in LeftRight (LR), Anterior-Posterior (AP), and Superior-Inferior (SI) directions for the upper (6 patients) and lower (10 patients Heinzerling et al. used 4DCT to show a reduction in movement of lower lung and liver tumors when using the same immobilization method, with a mean SI movement of 12.3 mm without abdominal press, which was further reduced to 7.5 mm and 6.1 mm with medium and high levels of compression, respectively. 19) Shioyama et al. used CT images to show a mean (± SD) reduction in intrafractional motion of lung or liver tumors along the SI direction from 9.9 (± 5.7) mm to 6.6 (± 6.3) mm when using a thermoplastic body cast combined with a vacuum pillow without abdominal compression. 20) Nemoto et al. used fluoroscopy to show upper lung tumor motion ranged from -5 mm to 3 mm in the SI direction when using an immobilization device they developed, which consisted of a body shell combined with a vacuum cushion, to minimize positioning inaccuracy when transferring a patient from a CT table to a linear accelerator table. 21) In the present study, from Table 2 and 3, the mean (± SD) ranges of GTV-COM motion around full exhalation in superior/inferior directions was 0.3 (± 0.6) / 1.9 (± 1.3) mm in the upper lobe, 0.0 (± 0.0) / 12.0 (± 5.7) mm in the lower lobe, and 0.2 (± 0.5) / 7.8 (± 6.9) mm in the whole lung. These results are generally comparable to those of previous studies into immobilization devices, although in the lower lobe along the SI direction the reduction was less notable compared with methods using the more uncomfortable abdominal press. Several limitations of this study warrant consideration. First, we observed only one respiratory cycle and therefore the effect of baseline drift and irregular respiratory pattern changes were not yet consideration. [31] [32] [33] [34] [35] Our results, however, showed a significant reduction in the range of tumor motion compared to our previous report 30) which is without the use of an immobilization device. This reduction therefore likely results from the immobilization itself, which reduces tumor motion even when respiratory pattern variations are taken into account.
Second, our study focused on intrafractional respiratory motion rather than calculated dose distribution. Although an understanding of dose distribution would more directly address the merits of our results with regard to radiotherapy, dose calculation was beyond the scope of this study. Our results showed, however, that immobilization could minimize excessive irradiation dosing to normal tissues by IM reduction compared to protocols without immobilization even in respiratory-gated therapy.
Our study left out of consideration possible inter-and intra-observer contouring errors . With the voxel size being 0.78 mm × 0.78 mm × 1 mm, there also exist delineation uncertainties of the order of ± 1 mm due to the voxel size itself. These uncertainties are, however, expected to be distributed like the Gaussian distribution. Moreover, since we calculated center of mass not a single voxel, this strategy could minimize manual contouring errors by averaging contour lines slice by slice. we did not quantify manual contouring errors, this is beyond this scope.
In conclusion, we examined the lung tumor motion using 4DCT and showed quantitatively the effectiveness of respiratory-gated treatment scenario. In addition, compared to results based on 4DCT data obtained without immobilization, the immobilization device used here itself was effective in reducing the range of respiratory-induced lung tumor motion. The quantitative evaluation of lung tumor motion when using an immobilization device is useful in particle beam therapy as well as external photon beam therapy, where tumor motion significantly affects dose distribution.
